Highlights the recent important findings in cancer heterogeneity
Author:
Open Access
- 1 June 2023
- journal article
- editorial
- Published by Springer Nature in Holistic Integrative Oncology
- Vol. 2 (1) , 1-5
Abstract
The therapeutic drugs, agents or techniques for the treatment of cancer could be misled since tumor tissues are frequently heterogeneous and hard to characterize. The changing of tumor microenvironments and epigenetics can mediate immunoescape and dampen the efficacy of adjuvant treatment. This short review highlights the recent important findings in cancer heterogeneity, including cancer immunology, epigenetics and genetic mutations, intratumoral microbiota and cancer stem cells, and contributing to the design of innovative cancer treatment strategy.Keywords
This publication has 16 references indexed in Scilit:
- The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodesCell, 2022
- Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsCell, 2022
- PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion programNature, 2022
- PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cellsNature, 2022
- Ordered and deterministic cancer genome evolution after p53 lossNature, 2022
- Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in ChinaJAMA Oncology, 2022
- Cell–matrix interface regulates dormancy in human colon cancer stem cellsNature, 2022
- Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironmentScience, 2022
- Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancerCell, 2022
- Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerCancer Cell, 2022